Improvement of hand function in stroke survivors Nervous System Diseases
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Community based stroke survivor 2. More than 6 months after suffering an ischaemic or haemorrhagic cortical or subcortical stroke of mild or moderate severity (Upper Extremity Fugl-Meyer score 29 or greater)
Exclusion criteria
Exclusion criteria: 1. Aphasia or other language problem making understanding the study and giving consent difficult (this only relates to medical difficulties caused by the stroke; for people with poor English language skills, a suitable translator will be arranged) 2. Cognitive impairment making understanding the nature of the study and giving informed consent difficult 3. Metal implants in the brain or skull, which would be a contraindication for transcranial magnetic brain stimulation (TMS) 4. A history of epilepsy (also a contraindication for TMS) 5. Shoulder subluxation, pain or other musculoskeletal difficulties such as contractures 6. An aversion to loud sounds
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Hand function will be assessed using the Box and Block Test, which counts the number of wooded blocks which can be transported across a barrier in one minute. This will be measured at each visit. Measures will be made in both most affected and least affected hand. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Hand function measured using Action Research Arm Test at each visit 2. Impairment measured using the Fugl-Meyer score at each visit 3. Power grip strength measured using a Jamar dynamometer at each visit 4. Pinch grip strength measured using a pinch grip dynamometer at each visit 5. Finger individuation measured using a custom device which measures digit flexion force at each visit 6. Motor evoked potentials in the first dorsal interosseous and flexor digitorum superficialis muscles measured using TMS over the motor cortex at a range of intensities above resting motor threshold, at each visit 7. Intracortical inhibition and facilitation in the first dorsal interosseous muscle measured using TMS over the motor cortex and electrical stimulation of the ulnar nerve at the wrist, at each visit 8. Short-latency afferent inhibition in the first dorsal interosseous muscle measured using TMS over the motor cortex and electrical stimulation of the ulnar nerve at the wrist, at each visit Measures 3, 4 and 5 will be assessed in both the most affected and least affected hands. All other measures will be assessed only in the most affected side. The improvement in all measures from visit 1 and visit 2 will be compared between those patients who used the game over this time, and those who did not. For patients who used the game between visit 1 and 2, the improvement from visit 1 to visit 3 will be used to assess whether there is a long-term benefit of the therapy. For patients who used the game between visit 2 and visit 3, the improvement from visit 2 to visit 3 will provide supplementary information on the efficacy of the therapy. | — |
Countries
England, United Kingdom